Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Geriatrics
Published in: BMC Geriatrics 1/2022

01-12-2022 | Care | Research

The short-term effect of a modified comprehensive geriatric assessment and regularly case conferencing on neuropsychiatric symptoms in nursing homes: a cluster randomized trial

Authors: Geir-Tore Stensvik, Anne-Sofie Helvik, Gørill Haugan, Aslak Steinsbekk, Øyvind Salvesen, Sigrid Nakrem

Published in: BMC Geriatrics | Issue 1/2022

Login to get access

Abstract

Aims

To investigate the short-term effect of implementing a modified comprehensive geriatric assessment and regularly case conferencing in nursing homes on neuropsychiatric symptoms.

Background

Neuropsychiatric symptoms are common and may persist over time in nursing home residents. Evidence of effective interventions is scarce.

Design

A parallel cluster-randomised controlled trial.

Methods

The intervention was monthly standardised case conferencing in combination with a modified comprehensive geriatric assessment. The control group received care as usual.
Main outcome measure.
The total score on the short version of the Neuropsychiatric Inventory (NPI-Q, 12-items).

Results

A total of 309 residents at 34 long-term care wards in 17 nursing homes (unit of randomisation) were included. The intervention care units conducted on average two case conference-meetings (range 1–3), discussing a mean of 4.8 (range 1–8) residents. After 3 months, there were no difference of NPI-Q total score between the intervention (-0.4) and the control group (0.5) (estimated mean difference = -1.0, 95% CI -2.4 to 0.5, p = 0.19). There was a difference in favour of the intervention group on one of the secondary outcome measures, the apathy symptoms (-0.5 95% CI: -0.9 to -0.1, p = 0.03).

Conclusion

In this study there were no short-term effect of case conferencing and modified comprehensive geriatric assessments after three months on the total score on neuropsychiatric symptoms. The intervention group had less apathy at 3 months follow-up compared to those receiving care as usual. The findings suggest that a more comprehensive intervention is needed to improve the total Neuropsychiatric symptoms burden and complex symptoms.

Trial registration

Due to delays in the organisation, the study was registered after study start, i.e. retrospectively in Clinicaltrials.gov # NCT02790372 at https://​clinicaltrials.​gov/​; Date of clinical trial registration: 03/06/2016.
Literature
1.
Lane NE, Wodchis WP, Boyd CM, Stukel TA. Disability in long-term care residents explained by prevalent geriatric syndromes, not long-term care home characteristics: a cross-sectional study. BMC Geriatr. 2017;17(1):49.PubMedPubMedCentralCrossRef
2.
Nakrem S, Vinsnes AG, Seim A. Residents’ experiences of interpersonal factors in nursing home care: A qualitative study. Int J Nurs Stud. 2011;48(11):1357–66.PubMedCrossRef
3.
Helvik AS, Engedal K, Benth JS, Selbaek G. Prevalence and Severity of Dementia in Nursing Home Residents. Dement Geriatr Cogn Disord. 2015;40(3–4):166–77.PubMedCrossRef
4.
Edberg AK, Bird M, Richards DA, Woods R, Keeley P, Davis-Quarrell V. Strain in nursing care of people with dementia: nurses’ experience in Australia, Sweden and United Kingdom. Aging Ment Health. 2008;12(2):236–43.PubMedCrossRef
5.
Zuidema S, Koopmans R, Verhey F. Prevalence and predictors of neuropsychiatric symptoms in cognitively impaired nursing home patients. J Geriatr Psychiatry Neurol. 2007;20(1):41–9.PubMedCrossRef
6.
Helvik A, Selbæk G, SaltyteBenth J, Røen I, Bergh S. Correction: The course of neuropsychiatric symptoms in nursing home residents from admission to 30-month follow-up. Plos One. 2018;13:e0209875.PubMedPubMedCentralCrossRef
7.
van der Linde RM, Matthews FE, Dening T, Brayne C. Patterns and persistence of behavioural and psychological symptoms in those with cognitive impairment: the importance of apathy. Int J Geriatr Psychiatry. 2017;32(3):306–15.PubMedCrossRef
8.
Helvik AS, Engedal K, Wu B, Benth J, Corazzini K, Røen I, et al. Severity of Neuropsychiatric Symptoms in Nursing Home Residents. Dementia and geriatric cognitive disorders extra. 2016;6(1):28–42.PubMedPubMedCentralCrossRef
9.
Cohen-Mansfield J. Theoretical frameworks for behavioral problems in dementia. Alzheimer’s Care Today. 2000;1(4):8.
10.
Kovach CR, Noonan PE, Schlidt AM, Wells T. A Model of Consequences of Need-Driven, Dementia-Compromised Behavior. J Nurs Scholarsh. 2005;37(2):134–40.PubMedCrossRef
11.
Hodgson NA, Gitlin LN, Winter L, Czekanski K. Undiagnosed Illness and Neuropsychiatric Behaviors in Community Residing Older Adults With Dementia. Alzheimer Dis Assoc Disord. 2011;25(2):109–15.PubMedPubMedCentralCrossRef
12.
Léger JM, Moulias R, Robert P, Vellas B, Chapuy PH, Monfort JC, et al. Agitation and aggressiveness among the elderly population living in nursing or retirement homes in France. International psychogeriatrics / IPA. 2002;14(4):405–16.CrossRef
13.
Rostad HM, Grov EK, Utne I, Halvorsrud L. Characteristics of nursing home residents with late-stage dementia and pain. Sykepleien Forskning 2019;14(79184):e-79184.
14.
Nelson ST, Flynn L. Relationship between missed care and urinary tract infections in nursing homes. Geriatr Nurs. 2015;36(2):126–30.PubMedCrossRef
15.
Tible OP, Riese F, Savaskan E, von Gunten A. Best practice in the management of behavioural and psychological symptoms of dementia. Ther Adv Neurol Disord. 2017;10(8):297–309.PubMedPubMedCentralCrossRef
16.
National Institute for Health and Care Excellence (NICE). Dementia: Supporting People with Dementia and their Carerers in Health and Social Care. London: NICE; 2006.
17.
18.
Whall AL, Kolanowski AM. The need-driven dementia-compromised behavior model–a framework for understanding the behavioral symptoms of dementia. Aging Ment Health. 2004;8(2):106.PubMedCrossRef
19.
Vernooij-Dassen M, Vasse E, Zuidema S, Cohen-Mansfield J, Moyle W. Psychosocial interventions for dementia patients in long-term care. Int Psychogeriatr. 2010;22(7):1121–8.PubMedCrossRef
20.
21.
Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. The Lancet. 2013;381(9868):752–62.CrossRef
22.
Pilotto A, Cella A, Pilotto A, Daragjati J, Veronese N, Musacchio C, et al. Three decades of comprehensive geriatric assessment: evidence coming from different healthcare settings and specific clinical conditions. J Am Med Dir Assoc. 2017;18(2):192.e1-192.e11.CrossRef
23.
Bird M, Llewellyn-Jones RH, Korten A. An evaluation of the effectiveness of a case-specific approach to challenging behaviour associated with dementia. Aging Ment Health. 2009;13(1):73–83.PubMedCrossRef
24.
Reuther S, Dichter MN, Buscher I, Vollmar HC, Holle D, Bartholomeyczik S, et al. Case conferences as interventions dealing with the challenging behavior of people with dementia in nursing homes: a systematic review. International psychogeriatrics / IPA. 2012;24(12):1891–903.CrossRef
25.
Phillips JL, West PA, Davidson PM, Agar M. Does case conferencing for people with advanced dementia living in nursing homes improve care outcomes? Evidence from an integrative review. Int J Nurs Stud. 2013;50(8):1122–35.PubMedCrossRef
26.
Lichtwarck B, Myhre J, Goyal AR, Rokstad A, Selbaek G, Kirkevold Ø, Bergh S. Experiences of nursing home staff using the targeted interdisciplinary model for evaluation and treatment of neuropsychiatric symptoms (TIME) - a qualitative study. Aging & mental health. 2019;23(8):966–75. https://​doi.​org/​10.​1080/​13607863.​2018.​1464116.
27.
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308–14.PubMedCrossRef
28.
Lichtwarck B, Selbaek G, Kirkevold Ø, Rokstad AMM, Benth JŠ, Lindstrøm JC, et al. Targeted Interdisciplinary Model for Evaluation and Treatment of Neuropsychiatric Symptoms: A Cluster Randomized Controlled Trial. Am J Geriatr Psychiatry. 2018;26(1):25–38.PubMedCrossRef
29.
30.
Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P, for the CNPTG. Consort statement for randomized trials of nonpharmacologic treatments: A 2017 update and a consort extension for nonpharmacologic trial abstracts. Ann Intern Med. 2017;167(1):40–7.PubMedCrossRef
31.
32.
Nakrem S, Stensvik GT, Skjong RJ, Ostaszkiewicz J. Staff experiences with implementing a case conferencing care model in nursing homes: a focus group study. BMC Health Serv Res. 2019;19(1):191.PubMedPubMedCentralCrossRef
33.
Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179–86.PubMedCrossRef
34.
Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell Scale for Depression in Dementia. Biol Psychiat. 1988;23(3):271–84.PubMedCrossRef
35.
Barca ML, Engedal K, Selbæk G. A Reliability and Validity Study of the Cornell Scale among Elderly Inpatients, Using Various Clinical Criteria. Dement Geriatr Cogn Disord. 2010;29(5):438–47.PubMedCrossRef
36.
Stensvik GT, Helvik AS, Nakrem S, Haugan G. Cornell’s Depression for Dementia Scale: A psychometric study among Norwegian nursing home residents. Arch Gerontol Geriatr. 2021;93:104325.PubMedCrossRef
37.
Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140(6):566–72.PubMedCrossRef
38.
Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412–4.PubMedCrossRef
39.
Weiner MF, Martin-Cook K, Svetlik DA, Saine K, Foster B, Fontaine CS. The quality of life in late-stage dementia (QUALID) scale. J Am Med Dir Assoc. 2000;1(3):114–6.PubMed
40.
Roen I, Selbaek G, Kirkevold O, Engedal K, Lerdal A, Bergh S. The Reliability and Validity of the Norwegian Version of the Quality of Life in Late-Stage Dementia Scale. Dement Geriatr Cogn Disord. 2015;40(3–4):233–42.PubMedCrossRef
41.
Finkel SI, Lyons JS, Anderson RL. A brief agitation rating scale (BARS) for nursing home elderly. J Am Geriatr Soc. 1993;41(1):50–2.PubMedCrossRef
42.
43.
Sommer OH, Engedal K. Reliability and validity of the Norwegian version of the Brief Agitation Rating Scale (BARS) in dementia. Aging Ment Health. 2011;15(2):252–8.PubMedCrossRef
44.
Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12(2):233–9.PubMedCrossRef
45.
Selbæk G, Engedal K, Benth JŠ, Bergh S. The course of neuropsychiatric symptoms in nursing-home patients with dementia over a 53-month follow-up period. Int Psychogeriatr. 2014;26(01):81–91.PubMedCrossRef
46.
Rapp MA, Mell T, Majic T, Treusch Y, Nordheim J, Niemann-Mirmehdi M, et al. Agitation in nursing home residents with dementia (VIDEANT trial): Effects of a cluster-randomized, controlled, guideline implementation trial. J Am Med Dir Assoc. 2013;14(9):690–5.PubMedCrossRef
47.
Campbell M, Grimshaw JM, Elbourne DR. Intracluster correlation coefficients in cluster randomized trials: empirical insights into how should they be reported. BMC Med Res Methodol. 2004;4:9.PubMedPubMedCentralCrossRef
48.
Haugan G. Meaning-in-life in nursing-home patients: a correlate with physical and emotional symptoms. J Clin Nurs. 2014;23(7–8):1030–43.PubMedCrossRef
49.
Theleritis C, Siarkos K, Politis AA, Katirtzoglou E, Politis A. A systematic review of non-pharmacological treatments for apathy in dementia. Int J Geriatr Psychiatry. 2018;33(2):e177–92.PubMedCrossRef
50.
51.
Terum TM, Testad I, Rongve A, Aarsland D, Svendsboe E, Andersen JR. The association between aspects of carer distress and time until nursing home admission in persons with Alzheimer’s disease and dementia with Lewy bodies. Int Psychogeriatr / IPA. 2021;33(4):337–45.CrossRef
52.
Lynn Snow A, Cook KF, Lin PS, Morgan RO, Magaziner J. Proxies and other external raters: methodological considerations. Health Serv Res. 2005;40(5 Pt 2):1676–93.PubMedPubMedCentralCrossRef
53.
Goyal AR, Bergh S, Engedal K, Kirkevold M, Kirkevold Ø. The course of anxiety in persons with dementia in Norwegian nursing homes: A 12-month follow-up study. J Affect Disord. 2018;235:117–23.PubMedCrossRef
Metadata
Title
The short-term effect of a modified comprehensive geriatric assessment and regularly case conferencing on neuropsychiatric symptoms in nursing homes: a cluster randomized trial
Authors
Geir-Tore Stensvik
Anne-Sofie Helvik
Gørill Haugan
Aslak Steinsbekk
Øyvind Salvesen
Sigrid Nakrem
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2022
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-022-02976-x

Other articles of this Issue 1/2022

BMC Geriatrics 1/2022 Go to the issue

Research

Impact of a dementia-friendly program on detection and management of patients with cognitive impairment and delirium in acute-care hospital units: a controlled clinical trial design

Study protocol

Developing a novel tool to assess the ability to self-administer medication in non-demented in-hospital patients: ABLYMED study protocol

Research

Do older adults with multimorbidity prefer institutional care than those without multimorbidity? The role of functional limitation

Research article

Sleep duration, genetic susceptibility, and Alzheimer's disease: a longitudinal UK Biobank-based study

Research

Factors associated with community commitment among older adults: a stratified analysis of community group leaders and members

Research article

Incidence of falls and fall-related injuries and their predictive factors in frail older persons with cancer: a multicenter study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits